Statins and risk of poststroke hemorrhagic complications.

about

The efficacy and safety of high-dose statins in acute phase of ischemic stroke and transient ischemic attack: a systematic review.

P2860

Q39183197-5FF13E83-18BB-4CA5-8700-A8C4A62C2702

P2860

Statins and risk of poststroke hemorrhagic complications.

Item

http://www.wikidata.org/entity/Q35970842

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Statins and risk of poststroke hemorrhagic complications.

@ast

Statins and risk of poststroke hemorrhagic complications.

@en

type

Item

label

Statins and risk of poststroke hemorrhagic complications.

@ast

Statins and risk of poststroke hemorrhagic complications.

@en

prefLabel

Statins and risk of poststroke hemorrhagic complications.

@ast

Statins and risk of poststroke hemorrhagic complications.

@en

P1476

Statins and risk of poststroke hemorrhagic complications.

@en

P2093

Azmil H Abdul-Rahim

http://www.w3.org/2001/XMLSchema#string

Jan F Scheitz

http://www.w3.org/2001/XMLSchema#string

Kennedy R Lees

http://www.w3.org/2001/XMLSchema#string

Matthias Endres

http://www.w3.org/2001/XMLSchema#string

Philip M Bath

http://www.w3.org/2001/XMLSchema#string

Rachael L MacIsaac

http://www.w3.org/2001/XMLSchema#string

VISTA collaboration

http://www.w3.org/2001/XMLSchema#string

P2860

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study.

Development, expansion, and use of a stroke clinical trials resource for novel exploratory analyses.

Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis.

Thrombolysis in stroke despite contraindications or warnings?

Statin use following intracerebral hemorrhage: a decision analysis.

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.

Discontinuation of statin treatment in stroke patients.

Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease.

P304

1590-1596

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000002606

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bob Siegerink

Christian H Nolte

P577

2016-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27016519

http://www.w3.org/2001/XMLSchema#string

P932

4844236

http://www.w3.org/2001/XMLSchema#string

Statins and risk of poststroke hemorrhagic complications.

about

P2860

P2860

Statins and risk of poststroke hemorrhagic complications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932